Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Kingdomway Group Company operates at commercial scale with a global footprint in the manufacture of nutritional supplements, APIs, pharmaceutical intermediates, and functional foods. It has achieved GMP certification for its facilities and invests heavily in R&D to expand its product portfolio. The company’s products are widely exported to markets including the US and Singapore. No clinical trial results are reported as the focus is on commercialized products rather than novel therapeutics.
Its subsidiary "Kingdomway (Jiangsu) Biotech Co., Ltd." serves as an R&D platform focused on biological enzymes for applications in medicine, cosmetics, and dietary supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiamen Kingdomway Group Company.